A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients

NCT04345692 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped RECOVERY Trial results - no efficacy

Conditions

COVID-19

Interventions

DRUG: Hydroxychloroquine

Sponsor

Queen's Medical Center